Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Hologic to acquire Reveal Genomics for oncology innovation

RECENTLY ACQUIREDOct 19, 2026

Acquiring Company

Hologic

Acquired Company

REVEAL GENOMICS S.L

MarlboroughBarcelonaBiotechnologyHealth CareMedicalMedical DeviceBiotechnology

Description

Hologic has announced a definitive agreement to acquire Reveal Genomics, enhancing its portfolio in women's health. Reveal Genomics specializes in precision oncology with advanced genomic diagnostic tests. This acquisition aims to bolster personalized treatment options for cancer patients, particularly in breast cancer care.

Company Information

Company

Hologic

Location

Marlborough, Massachusetts, United States

About

Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world’s first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; and minimally invasive surgical technologies for uterine fibroids, abnormal uterine bleeding and pediatric procedures. Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. SOURCE: Hologic, Inc.

Fundz sees it the moment Hologic makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hologic's next move

Learn about Strategic plan

Frequently asked

Who acquired REVEAL GENOMICS S.L?

REVEAL GENOMICS S.L was acquired by Hologic, based in Marlborough. The deal was reported on October 19, 2026. Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Hologic is privately held and operates in Biotechnology.

When did Hologic acquire REVEAL GENOMICS S.L?

Hologic's acquisition of REVEAL GENOMICS S.L was reported on October 19, 2026. Hologic has announced a definitive agreement to acquire Reveal Genomics, enhancing its portfolio in women's health. Reveal Genomics specializes in precision oncology with advanced genomic diagnostic tests. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does REVEAL GENOMICS S.L do?

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology start-up focused on revolutionizing precision oncology through biomarker innovation. It is privately held, operating in Biotechnology, and is based in Barcelona.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.